BI-6015

CAS No. 93987-29-2

BI-6015( BI 6015 | BI6015 )

Catalog No. M27480 CAS No. 93987-29-2

BI 6015 is an antagonist of HNF4α. HNF4α is a nuclear receptor that regulates gene expression in the intestine cells, liver cells, and pancreas-β cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 31 In Stock
5MG 50 In Stock
10MG 87 In Stock
25MG 192 In Stock
50MG 286 In Stock
100MG 429 In Stock
500MG 888 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BI-6015
  • Note
    Research use only, not for human use.
  • Brief Description
    BI 6015 is an antagonist of HNF4α. HNF4α is a nuclear receptor that regulates gene expression in the intestine cells, liver cells, and pancreas-β cells.
  • Description
    BI 6015 is an antagonist of HNF4α. HNF4α is a nuclear receptor that regulates gene expression in the intestine cells, liver cells, and pancreas-β cells.
  • In Vitro
    Cell Viability Assay Cell Line:Hep3B-Luc cells and primary hepatocytes Concentration:1.25, 2.5, 5, 10, 20 μM Incubation Time:24, 48, 72 hours Result:Was markedly toxic to Hep3B cells but spared primary hepatocytes.
  • In Vivo
    ——
  • Synonyms
    BI 6015 | BI6015
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    93987-29-2
  • Formula Weight
    331.35
  • Molecular Formula
    C15H13N3O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (150.90 mM)
  • SMILES
    Cc1nc2ccccc2n1S(=O)(=O)c1cc(ccc1C)[N+]([O-])=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Haf?z AM, et al. Protective and therapeutic effects of pyrrolidine dithiocarbamate in a rat tongue cancer model created experimentally using 4-nitroquinoline 1-oxide. Adv Clin Exp Med. 2020 Nov;29(11):1249-1254.
molnova catalog
related products
  • 3-Galloylquercitrin

    1. 3''-Galloylquercitrin possesses the activity for PTK inhibition.

  • L-Asparaginase

    L-Asparaginase (L-?ASNase), a hydrolase that catalyzes the conversion of L-asparagine, used in acute lymphoblastic leukemia treatment.Asparaginase is an enzyme that is used as a medication. As a medication, L-asparaginase is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin.

  • NSC45586

    NSC45586 is a protein phosphatase PHLPP inhibitor, which is selective for PHLPP1 and PHLPP2.